Biological and Clinicopathological Significance of Cripto-۱ Expression in the Progression of Human ESCC

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 223

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-5-2_002

تاریخ نمایه سازی: 10 شهریور 1400

Abstract:

Background: Human Cripto-۱, a member of the EGF-CFC family, is involved in embryonic development, embryonic stem cell maintenance, and tumor progression. It also participates in multiple cell signaling pathways including Wnt, Notch, and TGF-β. Remarkably, it is expressed in cancer stem cell (CSC) compartments, boosting tumor cell migration, invasion, and angiogenesis. Although Cripto-۱ is overexpressed in a variety of human malignant tumors, its expression in esophageal squamous cell carcinoma (ESCC) remains unclear. Our aim in this study was to evaluate the possible oncogenic role of Cripto-۱ in ESCC progression and elucidate its association with clinicopathological parameters in patients. Methods: In this study, Cripto-۱ expression in ۵۰ ESCC tissue samples was analyzed and compared to corresponding margin-normal esophageal tissues using quantitative real-time PCR. Results: Cripto-۱ was overexpressed in nearly ۴۰% of ESCC samples compared with normal tissue samples. Significant correlations were observed between Cripto-۱ expression and tumor differentiation grade, progression stage, and location (p < ۰.۰۵). Conclusions: Our results indicate that overexpression of Cripto-۱ is involved in the development of ESCC. Further assessment will be necessary to determine the role of Cripto-۱ cross talk in ESCC tumorigenesis.  

Authors

Reihaneh Alsadat Mahmoudian

Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Reza Abbaszadegan

Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran- Medical Genetics Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Mahdi Forghanifard

Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.

Meysam Moghbeli

Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Faezeh Moghbeli

Department Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Jamshidkhan Chamani

Faculty of Sciences, Department of Biochemistry and Biophysics, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Mehran Gholamin

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.